hodgkin disease
Showing NaN - NaN of 5
Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
-
Phoenix, Arizona
- +53 more
Aug 17, 2022
Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +2 more
-
Birmingham, Alabama
- +77 more
Jul 21, 2022
Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)
Completed
- Hodgkin Disease
- brentuximab vedotin
- bendamustine
-
Birmingham, Alabama
- +12 more
Jan 24, 2019
Hodgkin Disease Trial in United Kingdom (Brentuximab Vedotin)
Completed
- Hodgkin Disease
- Brentuximab Vedotin
-
Birmingham, United Kingdom
- +11 more
May 9, 2018
Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))
Completed
- Hodgkin Disease
- +4 more
- SGN-30 (monoclonal antibody)
-
Birmingham, Alabama
- +9 more
Oct 7, 2011